The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells

12Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Small ubiquitin-like modifier (SUMO)ylation is a reversible post-translational modification that plays a crucial role in numerous aspects of cell physiology, including cell cycle regulation, DNA damage repair, and protein trafficking and turnover, which are of importance for cell homeostasis. Mechanistically, SUMOylation is a sequential multi-enzymatic process where SUMO E3 ligases recruit substrates and accelerate the transfer of SUMO onto targets, modulating their interactions, localization, activity, or stability. Accumulating evidence highlights the critical role of dysregulated SUMO E3 ligases in processes associated with the occurrence and development of cancers. In the present review, we summarize the SUMO E3 ligases, in particular, the novel ones recently identified, and discuss their regulatory roles in cancer pathogenesis.

Author supplied keywords

Cite

CITATION STYLE

APA

Shi, X., Du, Y., Li, S., & Wu, H. (2022, April 1). The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms23073639

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free